Clinical Trial Update: Measuring Small-Airways Disease Improvement After Step-up to Extrafine TRIple or High-dose ICS/LABA in Patients Uncontrolled on Medium Dose ICS/LABA eXploring T2 Inflammation

View source ↗

Summary

A clinical trial evaluating whether stepping up to extrafine triple therapy or high-dose ICS/LABA improves small-airways disease in asthma patients uncontrolled…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• extrafine triple inhaled therapy
• high-dose ICS/LABA

Snippet

Sponsor: University Hospital, Ioannina | Conditions: Asthma | Status: NOT_YET_RECRUITING